Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00459654
Status:
COMPLETED
Last Update Posted:
2014-06-25
First Post:
2007-04-11
Brief Title:
A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer
Sponsor:
Bayer
Organization:
Bayer